Your browser doesn't support javascript.
loading
Host IDO2 Gene Status Influences Tumor Progression and Radiotherapy Response in KRAS-Driven Sporadic Pancreatic Cancers.
Nevler, Avinoam; Muller, Alexander J; Sutanto-Ward, Erika; DuHadaway, James B; Nagatomo, Kei; Londin, Eric; O'Hayer, Kevin; Cozzitorto, Joseph A; Lavu, Harish; Yeo, Theresa P; Curtis, Mark; Villatoro, Tatiana; Leiby, Benjamin E; Mandik-Nayak, Laura; Winter, Jordan M; Yeo, Charles J; Prendergast, George C; Brody, Jonathan R.
Afiliación
  • Nevler A; Departments of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Muller AJ; Sidney Kimmel Medical College and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Sutanto-Ward E; The Dr. P. Borenstein Talpiot Medical Leadership Program (2012), ChaimSheba Medical Center, Israel.
  • DuHadaway JB; Sidney Kimmel Medical College and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Nagatomo K; Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Londin E; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • O'Hayer K; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Cozzitorto JA; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Lavu H; Lankenau Institute for Medical Research, Wynnewood, Pennsylvania.
  • Yeo TP; Departments of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Curtis M; Departments of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Villatoro T; Departments of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Leiby BE; Departments of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Mandik-Nayak L; Sidney Kimmel Medical College and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Winter JM; Departments of Surgery and the Jefferson Pancreas, Biliary and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Yeo CJ; Sidney Kimmel Medical College and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Prendergast GC; Departments of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Brody JR; Departments of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Clin Cancer Res ; 25(2): 724-734, 2019 01 15.
Article en En | MEDLINE | ID: mdl-30266763
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Indolamina-Pirrol 2,3,-Dioxigenasa Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Biomarcadores de Tumor / Proteínas Proto-Oncogénicas p21(ras) / Indolamina-Pirrol 2,3,-Dioxigenasa Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article